transdermal

ImmunoPrecise Unveils AI-Designed GLP-1 Therapy Alternative with Transdermal Delivery Potential

ImmunoPrecise Antibodies (NASDAQ: IPA) has developed a new class of GLP-1 therapies using artificial intelligence…